Patients who have an ischemic stroke in the morning, or onset of their active period, are not only at a greater risk for poor outcome based on the hyperfibrinolytic morning state, but additionally, response to thrombolytic intervention is less efficacious during the morning time points
Kuan EC, Talati V, Patel JA, Nguyen TV, Abiri A, Pang JC, Goshtasbi K, Liu L, Craig JR, Papagiannopoulos P, Phillips KM, Tajudeen BA, Adappa ND, Palmer JN, Sedaghat AR, Wang EW, Anand V, Batra PS, Bergsneider M, Bernal-Sprekelsen M, Bleier BS, Cappabianca P, Carrau RL, Casiano RR, Castelnuovo P, Cavallo LM, Cohen MA, Dallan I, Eloy JA, El-Sayed IH, Evans JJ, Fernandez-Miranda JC, Ferrari M, Froelich S, Gardner PA, Georgalas C, Gray ST, Hanna EY , Harvey RJ, Hong SD, Hwang PH, Kelly DF, Kong DS, Lan MY, Lee JYK, Levine CG, Liu JK, Locatelli D, Meco C, McKean EL, Nicolai P, Nyquist GG, Omura K, Passeri T, Patel ZM, Celda MP, Neto CP, Prevedello DM, Rabinowitz MR, Raza SM, Recinos PF, Rosen MR, Sargi ZB, Schlosser RJ, Schwartz TH, Sindwani R, Snyderman CH, Stamm AC, Thorp BD, Turri-Zanoni M, Wang MB, Wang WH, Witterick IJ, Won TB, Woodworth BA, Wormald PJ, Zada G, Su SY
The results showed that the AAVO can inhibit the activation of the transient receptor potential of cation channel subfamily A member 1 channel and reduce the expressions of related neuropeptides and pro-inflammatory cytokines, thereby alleviating the inflammatory response
Another important metabolic regulation of bacterial infection through metabolism is that bacteria can reroute the macrophage metabolism to use nutrients for their own use which is nicely described elsewhere and might be a key in the macrophage response to infections (138141)
Song Y, Huang Y, Zhou F, Ding J, Zhou W (2022) Macrophage-targeted nanomedicine for chronic diseases immunotherapy
Intergovernmental Panel Climate Chang
